Clinical Handbook of Psychotropic Drugs

Versandkostenfrei!

Nicht lieferbar

Marktplatzangebote

Quick and comprehensive information on psychotropic drugs for adults.Accurate and up-to-dateComparison charts help decision-makingIcons with full colorAvailable both in print and onlineDownloadable patient information sheetsMore about this bookThe Clinical Handbook of Psychotropic Drugs has become a standard reference and working tool for psychiatrists, psychologists, physicians, pharmacists, nurses, and other mental health professionals.Independent, unbiased, up-to-datePacked with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions...) for a quick overview of treatment optionsSuccinct, bulleted information on all classes of medication: on- and off-label indications, (US FDA, Health Canada), recommended dosages, US and Canadian trade names, side effects, interactions, pharmacodynamics, precautions in the young, the elderly, and pregnancy, nursing implications, and much more - all you need to know for each class of drugPotentialinteractions and side effects summarized in comparison chartsWith instantly recognizable icons and in full color throughout, allowing you to find at a glance all the information you seekClearly written patient information sheets available for download as printable PDF filesThis book is a must for everyone who needs an up-to-date, easy-to-use, comprehensive summary of all the most relevant information about psychotropic drugs.New in this editionAntidepressants chapter includes a new section on the NMDA receptor antagonist/CYP2D6 inhibitor combination product (dextromethorphan/bupropion)Antipsychotics updates include revised clozapine monitoring tables which now also contain monitoring requirements for patients with or without non-benign ethnic neutropeniaMood Stabilisers sections on Lithium and Anticonvulsants extensively revisedDementia chapter includes a new section on lecanemab, a new fast-track FDA-approved treatment for Alzheimer's diseaseTreatment of Substance Use Disorders includes revisions to buprenorphine dosing section that include a rapid micro-induction method (Bernese method) that allows treatment to start without waiting for patient to be in withdrawalUnapproved treatments of Psychiatric Disorders, Natural Health Products, and Pharmacogenetics chapters all substantially revisedNew formulations and trade names include: Auvelity (dextromethorphan/bupropion extended-release tablets), Invega Hafyera (paliperidone 6-monthly IM injection), Leqembi (lecanemab infusion), Subutex (buprenorphine sublingual tablets), Quviviq (daridorexant tablets)

Weniger Details